Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma—experience of the BriTROC consortium-Reference-Cited by-同舟云学术

Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma—experience of the BriTROC consortium

Published:2017-03-30 Issue:10 Volume:116 Page:1294-1301
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Goranova T, ,Ennis D,Piskorz A M,Macintyre G,Lewsley L A,Stobo J,Wilson C,Kay D,Glasspool R M,Lockley M,Brockbank E,Montes A,Walther A,Sundar S,Edmondson R,Hall G D,Clamp A,Gourley C,Hall M,Fotopoulou C,Gabra H,Freeman S,Moore L,Jimenez-Linan M,Paul J,Brenton J D,McNeish I A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc201786.pdf

Reference25 articles.

1. Aghajanian C, Blank SV, Goff BA, Judson PL, Teneriello MG, Husain A, Sovak MA, Yi J, Nycum LR (2012) OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Clin Oncol 30 (17): 2039–2045.

2. Ahmed AA, Etemadmoghadam D, Temple J, Lynch AG, Riad M, Sharma R, Stewart C, Fereday S, Caldas C, Defazio A, Bowtell D, Brenton JD (2010) Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol 221 (1): 49–56.

3. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2 (5): 401–404.

4. Edwards SL, Brough R, Lord CJ, Natrajan R, Vatcheva R, Levine DA, Boyd J, Reis-Filho JS, Ashworth A (2008) Resistance to therapy caused by intragenic deletion in BRCA2. Nature 451 (7182): 1111–1115.

5. El-Osta H, Hong D, Wheler J, Fu S, Naing A, Falchook G, Hicks M, Wen S, Tsimberidou AM, Kurzrock R (2011) Outcomes of research biopsies in phase I clinical trials: the MD anderson cancer center experience. Oncologist 16 (9): 1292–1298.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United Kingdom;International Journal of Gynecologic Cancer;2024-09

2. The genomic trajectory of ovarian high‐grade serous carcinoma can be observed in STIC lesions;The Journal of Pathology;2024-07-02

3. Molecular landscape and functional characterization of centrosome amplification in ovarian cancer;Nature Communications;2023-10-16

4. The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma;Nature Communications;2023-07-20

5. Heme oxygenase-1 expressing omental macrophages as a therapeutic target in ovarian high grade serous carcinoma;2023-07-19